Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H K Kroemer

Showing results (1-10 of 114) with videos related to

Pageof 12
Sort By:
Pharmacology & Therapeutics|January 1, 1991
The drug interaction potential of ranitidine: an updateU Klotz, H K Kroemer
International Journal of Clinical Pharmacology and Therapeutics|February 1, 1997
Dose-dependency of oxazaphosphorine pharmacokineticsD Busse, H K Kroemer
Herz|March 14, 2014
[Personalized medicine in cardiology?]H K Kroemer, G Hasenfuß
Fortschritte Der Medizin|September 30, 1991
[The interaction potential of H2 receptor antagonists. A short current review]U Klotz, H K Kroemer
Clinical Pharmacokinetics|October 1, 1992
Glucuronidation of drugs. A re-evaluation of the pharmacological significance of the conjugates and modulating factorsH K Kroemer, U Klotz
Life Sciences|January 1, 1995
"It's the genes, stupid". Molecular bases and clinical consequences of genetic cytochrome P450 2D6 polymorphismH K Kroemer, M Eichelbaum
Journal of Clinical Pharmacology|January 1, 1997
Use of probe drugs as predictors of drug metabolism in humansK T Kivistö, H K Kroemer
Fortschritte Der Medizin|August 30, 1995
[Mirror, mirror on the wall--stereoselectivity of drug effects]M F Fromm, H K Kroemer
Toxicology Letters|December 1, 1992
Genetically determined differences in drug metabolism as a risk factor in drug toxicityM Eichelbaum, H K Kroemer, G Mikus
Journal of Chromatography. B, Biomedical Sciences and Applications|March 3, 1999
In vitro cleavage of paracetamol glucuronide by human liver and kidney beta-glucuronidase: determination of paracetamol by capillary electrophoresisF Bohnenstengel, H K Kroemer, B Sperker
Pageof 12

Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
Pharmacology & Therapeutics|January 1, 1991
The drug interaction potential of ranitidine: an updateU Klotz, H K Kroemer
International Journal of Clinical Pharmacology and Therapeutics|February 1, 1997
Dose-dependency of oxazaphosphorine pharmacokineticsD Busse, H K Kroemer
Herz|March 14, 2014
[Personalized medicine in cardiology?]H K Kroemer, G Hasenfuß
Fortschritte Der Medizin|September 30, 1991
[The interaction potential of H2 receptor antagonists. A short current review]U Klotz, H K Kroemer
Clinical Pharmacokinetics|October 1, 1992
Glucuronidation of drugs. A re-evaluation of the pharmacological significance of the conjugates and modulating factorsH K Kroemer, U Klotz
Life Sciences|January 1, 1995
"It's the genes, stupid". Molecular bases and clinical consequences of genetic cytochrome P450 2D6 polymorphismH K Kroemer, M Eichelbaum
Journal of Clinical Pharmacology|January 1, 1997
Use of probe drugs as predictors of drug metabolism in humansK T Kivistö, H K Kroemer
Fortschritte Der Medizin|August 30, 1995
[Mirror, mirror on the wall--stereoselectivity of drug effects]M F Fromm, H K Kroemer
Toxicology Letters|December 1, 1992
Genetically determined differences in drug metabolism as a risk factor in drug toxicityM Eichelbaum, H K Kroemer, G Mikus
Journal of Chromatography. B, Biomedical Sciences and Applications|March 3, 1999
In vitro cleavage of paracetamol glucuronide by human liver and kidney beta-glucuronidase: determination of paracetamol by capillary electrophoresisF Bohnenstengel, H K Kroemer, B Sperker
Pageof 12